| Kratom Data 2022 (Food and Drug Administration) |
Awaiting Response |
Food and Drug Administration |
United States of America |
| Impulsaria LLC investigation |
Fix Required |
Food and Drug Administration |
United States of America |
| Adverse event reporting for the Johnson and Johnson COVID-19 Vaccine (Food and Drug Administration) |
Completed |
Food and Drug Administration |
United States of America |
| Premarket Application Review Prioritization Plan (CTP) |
Completed |
Food and Drug Administration |
United States of America |
| Emails Mentioning "Embargo" 2020-2021 (FDA Office of Media Affairs) |
Withdrawn |
Food and Drug Administration |
United States of America |
| Records - Dr. Marion Gruber and Dr. Philip Krause (FDA Office of Vaccines Research and Review) |
Awaiting Response |
Food and Drug Administration |
United States of America |
| Administrative Processing Records (FOIA Control #2021-5683) |
Completed |
Food and Drug Administration |
United States of America |
| Administrative Processing Records (FOIA Control #2021-5683) |
Withdrawn |
Food and Drug Administration |
United States of America |
| HR Records - Dr. Marion Gruber and Dr. Philip Krause (FDA Office of Vaccines Research and Review) |
Withdrawn |
Food and Drug Administration |
United States of America |
| FDA reports of adverse reaction and side effects from Vimpat/lacosamide (CSV/Excel) |
Completed |
Food and Drug Administration |
United States of America |